Overexpression of VSNL1 Enhances Cell Proliferation in Colorectal Carcinogenesis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of VSNL1 Enhances Cell Proliferation in Colorectal Carcinogenesis
Authors
Keywords
-
Journal
PATHOBIOLOGY
Volume -, Issue -, Pages 1-11
Publisher
S. Karger AG
Online
2023-10-12
DOI
10.1159/000533877
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phenotypic Heterogeneity Analysis of APC-Mutant Colon Cancer by Proteomics and Phosphoproteomics Identifies RAI14 as a Key Prognostic Determinant in East Asians and Westerners
- (2023) Rou Zhang et al. MOLECULAR & CELLULAR PROTEOMICS
- RFC5, regulated by circ_0038985/miR‐3614‐5p, functions as an oncogene in the progression of colorectal cancer
- (2023) Huihui Yao et al. MOLECULAR CARCINOGENESIS
- AKR1B10 negatively regulates autophagy through reducing GAPDH upon glucose starvation in colon cancer
- (2021) Wanyun Li et al. JOURNAL OF CELL SCIENCE
- Downregulation of ZNF395 Drives Progression of Pancreatic Ductal Adenocarcinoma through Enhancement of Growth Potential
- (2021) Shusaku Kurogi et al. PATHOBIOLOGY
- Glycogenes in Oncofetal Chondroitin Sulfate Biosynthesis are Differently Expressed and Correlated With Immune Response in Placenta and Colorectal Cancer
- (2021) Zi-Yi Wu et al. Frontiers in Cell and Developmental Biology
- Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer
- (2020) Robin M. J. M. van Geel et al. BRITISH JOURNAL OF CANCER
- Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer
- (2020) Sanne C. F. A. Huijberts et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway
- (2020) Yizhou Yao et al. Aging-US
- VSNL1 Promotes Gastric Cancer Cell Proliferation and Migration by Regulating P2X3/P2Y2 Receptors and Is a Clinical Indicator of Poor Prognosis in Gastric Cancer Patients
- (2020) Qiao-Qiong Dai et al. Gastroenterology Research and Practice
- Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker
- (2019) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
- (2018) Eric Van Cutsem et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy
- (2017) Vincent Chung et al. JAMA Oncology
- Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma
- (2016) N. Hijiya et al. CANCER RESEARCH
- Colon adenoma features and their impact on risk of future advanced adenomas and colorectal cancer
- (2016) Audrey H Calderwood et al. World Journal of Gastrointestinal Oncology
- Antitumor Activity in RAS-Driven Tumors by Blocking AKT and MEK
- (2014) A. W. Tolcher et al. CLINICAL CANCER RESEARCH
- Development and progression of colorectal cancer based on follow-up analysis
- (2014) Takashi Hisabe et al. Digestive Endoscopy
- A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas
- (2014) Jeffrey R. Infante et al. EUROPEAN JOURNAL OF CANCER
- AKR1B10, a Transcriptional Target of p53, Is Downregulated in Colorectal Cancers Associated with Poor Prognosis
- (2013) T. Ohashi et al. MOLECULAR CANCER RESEARCH
- Visinin-like protein-1 overexpression is an indicator of lymph node metastasis and poor prognosis in colorectal cancer patients
- (2011) Tomonori Akagi et al. INTERNATIONAL JOURNAL OF CANCER
- Phosphorylation status of epidermal growth factor receptor is closely associated with responsiveness to gefitinib in pulmonary adenocarcinoma
- (2008) Naoki Hijiya et al. HUMAN PATHOLOGY
- VILIP-1 Downregulation in Non-Small Cell Lung Carcinomas: Mechanisms and Prediction of Survival
- (2008) Jian Fu et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started